Medical imaging dev IschemaView said yesterday that it launched its Rapid Angio neuroimaging system designed for use in the angiography suite.
The Menlo Park, Calif.-based company said that it partnered with Siemens (NYSE:SI) to integrate the Rapid software with Siemens’ SyngoDynaCT multiphase system for the newly launched imaging solution.
Siemens’ SyngoDyna CT Multiphase is a 3D image acquisition technique which uses multiple rotations of a C-arm system to acquire multi-phasic 3D representation of the brain and its perfusion.
“The Rapid Angio module, by combining the best-in-class syngoDynaCT system with the Rapid platform, allows for the direct evaluation of acute stroke patients in the angiography procedure room, saving precious time. Rapid Angio provides the most comprehensive real-time brain images for use in stroke treatment decisions, making this integration the most sophisticated angiography neuroimaging option available today,” worldwide operations senior VP Dr. Anil Singhal said in a prepared statement.
IschmaView said that its Rapid platform is intended to automatically produce CT perfusion maps to identify brain regions with reduced cerebral blood flow and blood volume and delayed contrast arrival, and touted it as the only neuroimaging platform FDA cleared for thrombectomy indications.
“Rapid directly in the angio suite will help our specialists treat the right patients even faster. Having the most advanced RAPID technology available in both the radiology department and the operating theater provides the best options for our doctors and patients,” Jian Ming Liu of China’s Changhai Hospital said in a press release.
In January, IschemaView said that it won expanded FDA clearance for its Rapid neuroimaging platform intended for use in selecting patients likely to benefit from endovascular thrombectomy.
